Keeping Investing Positive and Informative
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Great sentiment and perspective, Hadie! You know we have something when we are just as strong on the stock when the price goes red as when it goes green.
As the Charlie Munger quote goes:
"The big money is not in the buying and the selling...but in the waiting."
Huge, and the first in a series! Multiple acquisitions coming.
For the new guys not yet up to speed on the DD, check out the TRON PR's.
InMed, plus a SERIES of acquisitions mentioned here:
https://www.otcmarkets.com/stock/TRON/news/Toron-Inc-OTCTRON-Provides-Corporate-Status-Update?id=190548
And reiterated here:
https://backend.otcmarkets.com/otcapi/company/dns/news/document/30853/content
Thank you, PST! This company is solid as a rock. Let them thin it out on shakes and walk downs, and it'll be even thinner going up, just like we keep experiencing. Chart had an RSI(14) in the 90's as we hit fresh new highs today. All in all, I'd say we're doing great! Bring on the .02's! Tomorrow or whenever. They're coming back regardless.
$TRON 5yr Weekly Candlestick Chart(for the big picture in a single snapshot):
https://www.tradingview.com/x/Jn5CW1w9/
Plus we still have the value of the hospital itself and the respective medical equipment to take into account as part of our future assets and holdings. Pretty sweet!
Dip and rip! Nothing has changed about the fundamentals of the company. Know what you own. Remember, we got walked down to sub zero two(.002) and people thought this was hopeless and never going back up, while others saw it and bought the fear. Keep a cool head. We are tenfold higher than sub zero two on a shake. And we have a big deal closing soon here. Look for games between now and then, and also look for traders selling the news. Don't fear. Two more acquisitions(at least) after InMed. .02 will soon be the new .002. Hang tight and relax!
You're welcome, Jo! Anytime.
It is(mostly) a good thing. I believe you mentioned being new to stocks, so here is a quick explanation.
The shares in the float are the number of shares from the outstanding share count that can be traded. Outstanding shares minus restricted shares equals float.
Why is this important? Once the float is locked, the supply/demand ratio is much improved, creating volatility, or increased ability to move in a given direction.
If you have ten really rare paintings, and five of them are being held and not for sale, and then three more get destroyed in a fire at the auction house, how much more valuable do the remaining paintings become? That is pretty much how the float locking works. Maybe someone else has a better way of explaining this, but this is what comes to mind.
I can't wait for that moment to happen! That is going to be really, really great. And to think that that is only the first acquisition in a series. Talk about a first class investment! $TRON for the win!
What an awesome day here! News hasn't even hit, and this is still far from on the radars of the investing public. Float is locking, accumulation line is screaming, pricing is making a great upward move and dips are now seen as cheap shares rather than sentiment crushers, and no one seems to be in a rush for news, signalling that people know what they own and have zero problem waiting.
Three month chart is a thing of beauty and could open up from here in a big way with some very large bull candles.
https://www.tradingview.com/x/3VHLAIrB/
Awesome week! It is really a nice thing to see a technical/chart run before the fundamental/news-based run even begins. Nothing like a steady riser.
My guess would be around $1.00. Each time a stock loses a zero and moves a decimal place, a new class of investor is willing to enter. InMed will take us to .10 or better, and with a few new acquisitions, ImedScan sales and distribution, plus the launch of the ICO, and the subsequent value the token adds to the company's inherent worth, coupled with an influx of retail investor awareness, which we are not even scratching the surface of right now, seeing as we are hardly on the radars(even with our low float), then $1.00 is not far fetched in the future. I doubt we'll see it in six months, but I would not see it as out of the question in the next 12-18months, which at that point, we could then climb higher due to being priced at a level that big board institutional firms begin taking positions in. All that said, we could see larger investment through the gates sooner, given Rene's background and connections. Anyway, those are my thoughts.
You are very welcome, John! Thank you as well! $TRON Long and Strong
Hey John, here is the link to the email Rene sent me. You have a good memory. Rene is building a real company, not just a stock. When an OTC CEO is focused on the stock, it's usually for their own benefit; but when they are focused on the company, usually the shareholders will benefit just the same, much like what we have here. I'm sticking this out much longer than just the InMed run. Too much more in the pipeline.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=138318749
Great heads up, dd96! We're in for a serious ride. InMed acqusition(s), plus a few other acquisition targets to come, iMedScan revs(see tweet below), and the ICO. My personal guess is that the ICO will be to launch iMedScan after the acquisitions so as to show the software being used as a working model within established medical facilities. Then the ICO can capitalize the launch and distribution, and the coin value itself will increase the book value of the company/stock upon any sustainable upward movement.
ToronInc
?
@IncToron
15h15 hours ago
More
iMedScan’s revenue model presents an up-front income boost. However, its long term financial strength is derived from its tremendous back-end revenue stream. iMedScan benefits from its recurring revenue derived from its two software applications, iMedScan Connect and iMedScan EDI
0 replies 1 retweet 4 likes
Reply Retweet 1 Liked 4 Direct message
Source:
iMedScan’s revenue model presents an up-front income boost. However, its long term financial strength is derived from its tremendous back-end revenue stream. iMedScan benefits from its recurring revenue derived from its two software applications, iMedScan Connect and iMedScan EDI
— ToronInc (@IncToron) May 28, 2018
#58 in return, Badger. Thank you!
Heck of a find. Nice going!
Ownership Status: Acquired/Merged
Acquirer: Toron
It's happening.
#282 in return, Tumultuous. Thank you!
I agree, John! There has been zero fluff or pumping by management, all PR's have substance and show progress, and all affiliated members have longstanding reputations and experience. InMed will only be the first of many dominoes to fall.
Rene has chosen his company well. I would not be surprised in the least if these were long-term personal/industry relationships. Regardless, Rene has enlisted an A-Team to partner with.
Mr. Gurevich has been an active real estate investor and developer for over 30 years, with $500 million of acquired and/or developed real estate investments spanning New York, New Jersey, Connecticut, Florida, Nevada, Europe and Israel. His extensive experience has enabled him to gain expertise in the complete development process, including land use and master planning, site selection, due diligence, project design, management, operations of the project post completion, and real estate law, especially as it relates to development, zoning, rezoning, and financing.
Mr. Gurevich holds a Juris Doctor Degree from the Benjamin Cardozo School of Law and a B.A from the City University of New York. In 1989, he founded Janoff & Gurevich, LLP, a real estate focused law firm.
Besides his business pursuits, Mr. Gurevich is involved with several charitable organizations
Eleonora Gurevich has been an active real estate investor and developer since leaving the accounting industry in 1993. She worked for several years as an auditor at Touche Ross and Arthur Young, both Big Eight accounting firms beginning in 1987.
Subsequently she later moved into the real estate business and is involved in all phases of real estate ownership including acquisition, development and management. Her real estate investments are/were situated in New York, New Jersey, Connecticut, Florida, Nevada, Europe and Israel. As of this date, she has acquired and/or developed more than $500 million worth of real estate. Mrs. Gurevich has a great understanding of the intricacies of real estate, especially as it relates to investment and financing.
Mr. Robert S. Mathes has over twenty-five years of corporate and investment banking experience in the real estate industry. Prior to his involvement with Continental, Mr. Mathes pioneered the launch of RMRE, LLC, a provider of real estate investment banking services that provided a full spectrum of capital raising and debt and equity due diligence evaluation services. At RMRE, he secured new sources of capital for its clients from lenders and investors, while also authoring and editing debt and equity offering memoranda. Moreover, Mr. Mathes formed a strategic partnership to introduce Loan Resolution Advisors LLC, an advisory firm dedicated to providing investment guidance on real estate debt portfolios to lenders. Mr. Mathes was also a member of the Advisory Board at New York Credit, a $100 million debt fund.
From 1986 through 2007 he was a Senior Relationship Manager in the commercial real estate groups of various foreign commercial banks. He led his own team and was responsible for directing marketing efforts which created over $5 billion in new business and often led efforts to syndicate these loans. At Calyon Financial, he marketed and designed credit tenant lease transaction structures that were executed as private placements and incorporated RVI policies.
Mr. Mathes earned an MBA from the Johnson School at Cornell University. He also holds a New York State Real Estate Broker’s license.
Vladimir Avidon has more than thirty years of diverse experience in Real Estate in all phases of Development and Construction Project Management starting from initial concept to final occupancy. He has developed large, midsize and small scale Commercial, Industrial and Residential projects.
In his 30+ years as an architect and the builder, he managed development and construction of numerous complex projects including; Medical Office Buildings, Industrial Warehousing, Factories and Production facilities, Large Retail and Office Developments, Large Multifamily Residential Projects and Single Family Homes. He manages an award-winning general contracting and construction management team and has been building structures of enduring quality and value for more than 25 years.
From new building construction, to tenant improvements, modernization, historic restoration and residential developments, his list of satisfied clients, repeat customers and landmark projects speaks to the dedication and work ethics Vladimir Avidon brings to CFC.
I'm guessing you're right. If one acquisition can book us 0.22 with a multiplier, then three acquisitions or more could get us to a dollar, even if only on a run. I believe Rene mentioned some bigger investors looking at the stock as well. That's what I interpret from this: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136889138 He appears to be delivering as promised on the first part, so I'll take his word for it about the investors as well. One or two whales can lock half of the float if they see a return. Fingers crossed. Catch you and the other guys back here over the weekend or whenever. Awesome day today for $TRON!
We sure do!
There really is! Especially coming from a CEO who does not pump the stock, even under the heat of frustrated/impatient shareholders. This is going to be a heck of ride! $TRON Long.
I would have to say at least that. One is one. Two is a couple or a pair. A series would then be three or more. So on the modest side, I'd say we have two more acquisition deals coming in addition to InMed. I'm going to be holding this stock for a good while. This is a no-stress return.
$TRON News: https://www.marketwatch.com/story/toron-inc-otctron-provides-corporate-status-update-2018-04-27
Awesome news today! This part is just amazing:
..."not only are they looking forward to closing Toron's first acquisition but would like to serve as Toron's financial partner moving forward as Toron looks to add additional healthcare facilities in a series of acquisitions."
Low float stock w MULTIPLE acquisitions in the pipeline, now with a financial partner.
Look at PST's valuation for TRON once InMed is acquired:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136862247
$0.22
Now factor in multiple health care acquisitions and a float that just gets locked.
Bidding war for shares once that happens. Less supply, more demand, bigger pps, better run, more attention.
Nice going, Rene! Thanks for keeping things modest and solid until it was time to release something substantial. You didn't pump your stock. You focused on your business. Awesome job, Sir! Looking forward to the InMed closing.
I think you're right, Nica. My guess is that this is only the first domino to fall. Once Rene acquires three medical facilities, one of which is the largest cardiovascular practice in NE Georgia, it could then be time to scout out struggling medical practices with solid equipment and buildings that are only lacking in their business model, or maybe additionally, some physicians and personnel. It could start in Georgia, but with a behind the curtain plan to go nationwide. I think we're in for a good ride.
I'd say that's a pretty big deal, PST. Awesome find!
From their website:
"The Heart Center at Northeast Georgia Medical Center is the largest cardiovascular practice in Northeast Georgia with board certified and fellowship trained cardiovascular physicians practicing in the areas of Consultative Cardiology, Heart Failure & Transplantation, Electrophysiology, Invasive & Interventional Cardiology and Advanced Cardiovascular Imaging. Many of our physicians hold double board certifications in these subspecialties. We take a comprehensive approach to cardiac and vascular healthcare through state-of-the-art technology and techniques. We have the resources to treat any type of cardiovascular issue a patient could encounter within one group."
With emphasis(read three times and let the potential magnitude set in):
".....is the largest cardiovascular practice in Northeast Georgia....."
Or how about this?
"The physicians at The Heart Center provide a skill-set unmatched in experience, performing more than 5,000 cardiac procedures and consulting more than 30,000 patients each year."
More than 30,000 patients per year?
Two more facilities + Imedscan?
+ICO?
+Future M and A activities, sales, expansions, etc?
And a 299M float?
$TRON Patient, relaxed and waiting.
It could very well be how the game is played. He could cut his share structure in half if he lets this tank. On a personal level, that would be a kick to long-term holders who sell due to risk aversion or inability to hold at a loss. As far as ice cold business, no consideration for anyone but the most loyal of the most loyal, that would be extremely effective. Tank it, buy it up, lock the rest, close the merger, announce it, piggyback with an array of other news. It all depends on how he plays his hand and who/what is most valuable in his equation. To answer your question a bit more directly: It is a strong possibility; not a certainty, but nothing that should be in any way overlooked.
Nice going! I think that'll happen for you.
MIAMI, FLORIDA – 27 March 2018 - Toron, Inc. (OTC Pink: TRON) provided its
stockholders today with a corporate update.
“We are pressing forward to finalize our financing to complete our acquisition of the InMed Group.
As we are approaching Easter and Semana Santa, we anticipate that our financing will be
completed following this holiday season.” stated Rene Ortiz Morentin, President of Toron. “On
March 13, 2017, we received the InMed Group December 31, 2017 financial statements, which
was required by our lenders. These have been disseminated to our lenders and I have been talking
diligently with several financial institutions to provide the needed financing to complete this
transaction and launch our corporate vision.” further stated Ortiz Morentin.
The part that keeps replaying for me, is the last line:
" to complete this
transaction and launch our corporate vision."
Notice the "AND"?
Sounds like there is much more coming than just the completion of this transaction.
Hope all is well, Pennystock_es! $TRON long and strong for the win.
It could have something to do with this:
"This acquisition would provide Dewmar with expanded market reach for its existing and new consumer goods. In fact, if the acquisition is closed, new products can be piloted at the 120,000 square foot wholesale facility to build up the brand's sales track record before Dewmar presents them to big box retailers. Post-acquisition, International Wholesale Club plans to add an extra 40,000 to 60,000 square feet to accommodate expected growth."
Source: http://www.marketwired.com/press-release/dewmar-international-bmc-inc-dewm-plans-acquire-india-imports-llc-150-million-annual-pinksheets-dewm-2229995.htm
If International is buying up the surrounding block, given that CE mentioned it already being about a block, then it could be a welcome sign that they are prepping for expansion, to the tune of an extra 1/3 to 1/2 of their existing facility. Many seem frustrated by Marco's silence on the merger, but if the expansion is taking place for that purpose, it could be for good reason. Any CEO or investor on the otc knows silence is your best friend when you are a start-up entering into a big deal. You let it leak too early, your deal gets crushed.
And to save the bears some wind, yes, anything could happen and it could go the other way. We've all read your posts and like the cheap shares as much as you do.
I'm going to let that one ride and see what comes back. Persistence has its merits, no denying that, but one thing I have found with CEOs over the years is that they either are communicative or they aren't. The ones that are usually only trade respect once respect is already given. If this guy is solid, I don't want him to close communications with us before they get a chance to open. That said, if other shareholders have questions and are polite, no harm writing to him. It's also a personality game. Certain people click with certain people. Never know which person has the luck.
Man. Okay. Let's hope they have some solid revenues and assets backing this. If revs are solid, it can still go up with mild O/S increases. Fingers crossed.
Thanks, Cool. I wanted to make sure this guy gets the benefit of the doubt.
I will post any replies on the board. I will also let him know that I will be doing that so lines of communication stay open should he care to correspond.
That is a great question, one I hope is addressed as well. Let's hope he made that decision in order to leave headroom for funding and liquidity once on the big boards; of course if that was never the plan, then we know how the other side of the story goes.
As mentioned early, this thing could go either way. I just sent off an email expressing some of my thoughts. It is obviously up to the CEO from here. Let's hope his intentions are noble and his plan is sound.
Greetings, Sir:
I am writing regarding Lead Innovation. I have noticed the filings and the takeover of the HTIC stock ticker. Congratulations on the finalization of your deal and on the name change.
In today's filing, a 1 for 800 stock split was disclosed. Some see that as a bad thing; I see it as something that can be either good or bad, depending on execution.
As CEO, I am aware that you hold two-thirds of the outstanding shares, with my teammates/fellow long term shareholders and I holding a portion of the remaining one-third.
Seeing as we all stand to be positively affected, or adversely affected by the upcoming split, I wanted to write in hopes that you and your team will create a resolution to the split that is shareholder-friendly.
I am guessing with a split of that magnitude, your company does not want to remain on the OTCBB, but rather on AMEX, NYSE, or NASDAQ.
If at all possible, please follow up the reverse split with a press release that guides shareholders not only as to the direction of the company, but also, the intention for the split, the odds of dilution after the split(*we don't want to see a great split that free falls afterward), and the plans to create additional shareholder value via increasing the value of the company and the stock within the coming year.
I appreciate your time, and am currently holding out for the best. If it is your goal to take this to a major exchange, and you have the plan of execution in mind, coupled with the revenues to hold the price and delay dilutive funding/notes, then please allow me to express my gratitude in advance. Our long-term shareholders all really respected Harvey's commitment to honoring us with his way of doing business. We are standing by, some more patiently than others, with hopes to hold you and your company in equally high esteem as we do Harvey and Hi-Tec.
Thank you for making note of my thoughts and considerations, and congratulations again on the new public listing.
Kind Regards,
**** ********
Let's see what happens, guys. I took the gamble in full acceptance of it going in either direction. That said, I am hoping for the best. If done right, and with honor of all in mind, this could be a good move.
You are welcome. Yeah, even at .005, we are at $4. I'm curious as to how they are going to play their hand, and as to what's behind the curtain. This could result in a very nice uplisting and a solid holding to follow. Hoping the best for all of us.
Yep, anything can happen on the other side of this. All depends on motive and strategy on the part of the company. I am holding as well. I've been in since .0038. I'll take the risk.
Best case: They R/S, uplist, announce Linghang as well as Lead, put out revs, and this thing takes off. Then to follow, is only enough post-split dilution to keep the uplisted stock liquid.
Worst case: They R/S and dilute this all the way back down. Rinse and repeat. No future value.
The truth could lie somewhere in the middle as well. New CEO owns most of the O/S. Unless he converted his own shares from common to preferred just before the split, then he is in it with us. But then that yields one last question. How much is he counting on those shares to make him money as part of his plan? If he calculates his real money being made outside of the market, then the shares are for sleight of hand; but if not, then they stand to be a tremendous asset.
We have blast off coming on all fronts, Eddie. Technical and fundamental. This is one of those perfect setups for a massive move. Low float, much of it locked, chart can only get walked down a few shares at a time, more buyers are competing for less available shares, and news is ready to drip at any time. Doesn't get much better than this.
The action here is win-win. If the price goes up, then we're green. If we see these tiny, low volume walkdowns, then the RSI gets cooled and coils us to bounce higher with more headroom on a cooler chart. RSI is now at 58, cooling from 70. Again, cooled on low volume. Immediate accumulation is showing no significant downward change in trend, and is not trending down parallel to the RSI or pps. That signals to me that there is great potential for this to be even thinner moving back up in preparation for news. Technical traders may be making multiple entries and exits, but most of us here are holding, and some even adding. We're good. Nothing to sweat and all to gain.
Great rundown, Rain. RXMD just ran to a little over a quarter on $20.1M revs against a 330M float. HTIC(*hopefully soon to be LING!) would have those same revs, based on your estimates, but with a float less than one-third the size of RXMD. Whether Linghang, Lead Innovation, or both, we're in for a good ride.